Evidence map›Paper›PMID 39420305›Full record

ArticleBMC public health2024

Drivers of COVID-19 vaccine uptake among rural populations in Madagascar: a cross-sectional study.

Irina Kislaya, Diavolana Koecher Andrianarimanana, Valentina Marchese, Lalatiana Hosay, Rakotonavalona Rivomalala, Ramananjanahary Holinirina, Tahinamandranto Rasamoelina, Alexina Olivasoa Tsiky Zafinimampera, Sonya Ratefiarisoa, Olivette Totofotsy and 11 more

Abstract read
In one paragraph

Article in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Irina KislayaDepartment of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Strasse 74, D-20359, Hamburg, Germany.
Diavolana Koecher AndrianarimananaCentre Hospitalier Universitaire (CHU) Androva, Mahajanga, Madagascar.
Valentina MarcheseDepartment of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Strasse 74, D-20359, Hamburg, Germany.
Lalatiana HosayDirection Régionale de la Santé Publique Boeny, Mahajanga, Madagascar.
Rakotonavalona RivomalalaVaccination Program, Ministry of Public Health, Antanarivo, Madagascar.
Ramananjanahary HolinirinaVaccination Program, Ministry of Public Health, Antanarivo, Madagascar.
Tahinamandranto RasamoelinaCentre d'Infectiologie Charles Mérieux, Antananarivo, Madagascar.
Alexina Olivasoa Tsiky ZafinimamperaCentre Hospitalier Universitaire (CHU) Androva, Mahajanga, Madagascar.
Sonya RatefiarisoaCentre Hospitalier Universitaire (CHU) Androva, Mahajanga, Madagascar.
Olivette TotofotsyCentre Hospitalier Universitaire (CHU) Androva, Mahajanga, Madagascar.
Rivo RakotomalalaCentre Hospitalier Universitaire (CHU) Androva, Mahajanga, Madagascar.
Pia RauscheDepartment of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Strasse 74, D-20359, Hamburg, Germany.
Cheick Oumar DoumbiaDepartment of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Strasse 74, D-20359, Hamburg, Germany.
Ariane GuthDepartment of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Strasse 74, D-20359, Hamburg, Germany.
Viola PavoncelloDepartment of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Strasse 74, D-20359, Hamburg, Germany.
Simon VeilleuxDepartment of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Strasse 74, D-20359, Hamburg, Germany.
Zely Arivelo RandriamanantanyMinistry of Public Health of Madagascar, Antananarivo, Madagascar.
Jürgen MayDepartment of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Strasse 74, D-20359, Hamburg, Germany.
Dewi Ismajani PuradiredjaDepartment of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Strasse 74, D-20359, Hamburg, Germany.
Rivo Andry RakotoariveloMinistry of Public Health of Madagascar, Antananarivo, Madagascar.
Daniela FuscoDepartment of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Strasse 74, D-20359, Hamburg, Germany. fusco@bnitm.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe WHO set the global immunisation threshold for COVID-19 at 70% to achieve worldwide protection against the disease. To date, global COVID-19 vaccine coverage is still below this threshold, in particular in several sub-Saharan African (SSA) countries, such as Madagascar. While factors influencing COVID-19 vaccine hesitancy have been widely explored in the past few years, research on drivers of COVID-19 vaccine uptake remains scarce. This study aimed at investigating drivers associated with COVID-19 vaccine uptake in the Boeny region of Madagascar.

methodsThe study used a cross-sectional survey design to collect data on drivers of vaccine uptake from a sample of adults recruited from 12 healthcare facilities between November 2022 and February 2023. Relative and absolute frequencies were used to summarize participants' characteristics. Prevalence ratios were estimated by Poisson regression to identify and compare sociodemographic and motivational drivers of vaccine uptake among those who were willing to get vaccinated against COVID-19 with those who had already been vaccinated.

resultsA total of 928 participants aged between 18 and 76 years were included in the study. Among those recruited, 44.9% (n = 417) had already been vaccinated and 55.1% (n = 511) were willing to receive their first dose of COVID-19 vaccine on the day of the interview. The proportions of those respondents who live in urban areas (56.5% vs. 43.8%) and who have high school or university education (46.6% vs. 35.8%) were higher for the uptake group, whereas the proportion of employed respondents (66.3% vs. 56.5%) was higher among those willing to get vaccinated. Vaccine being free of charge (aPR = 1.77 [CI 95%: 1.45-2.17]) and being able to travel again (aPR = 1.61 [CI 95%: 1.30-1.98]) were the drivers most strongly associated with higher vaccine uptake after adjustment for sociodemographic factors.

conclusionsThis study shows that actual COVID-19 vaccine uptake is influenced by a different set of factors than willingness to get vaccinated. Taking this difference in drivers into account can inform more tailored vaccination strategies to increase worldwide coverage.

Indexed as

COVID-19COVID-19 VaccinesRural PopulationAdolescentAdultAgedCross-Sectional StudiesFemaleHumansMadagascarMaleMiddle AgedSARS-CoV-2Vaccination HesitancyYoung AdultCOVID-19 VaccinesCOVID-19COVID-19 vaccinationPublic healthVaccination strategiesVaccination uptakeVaccination willingness

Identifiers

PMID39420305
PMCPMC11487794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.